Navigenics Stock
Personal genomics
Sign up today and learn more about Navigenics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Navigenics Stock
Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.
Funding History
| 2007-11-01 | $25.0M |
|---|---|
| 2010-02-01 | $18.0M |
Management
Co-Founder
David B. Agus
Co-Founder, Chief Science officer
Dietrich Stephan
CEO
Vance Vanier
CFO
Matthew Garrett
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
